Edwards Lifesciences EW
NYSE EW
$86.16 -0.56 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) FCF Margin Growth (1y) (2010 - 2026)

Analysis

Edwards Lifesciences (EW) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 194.00
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 984.00
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 641.00
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 66.00
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 119.00
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 1,788.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -177.00
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -395.00
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -473.00
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn 229.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,788.00
Mar 31, 2026 -1,716.00
Dec 31, 2025 3,532.00
Sep 30, 2025 1,109.00
Jun 30, 2025 -517.00
Mar 31, 2025 2,482.00
Dec 31, 2024 -1,661.00
Sep 30, 2024 -650.00
Jun 30, 2024 2,201.00
Mar 31, 2024 -2,962.00
Dec 31, 2023 -4,594.00
Sep 30, 2023 969.00
Jun 30, 2023 -2,216.00
Mar 31, 2023 423.00
Dec 31, 2022 2,841.00
Sep 30, 2022 -1,701.00
Jun 30, 2022 -1,216.00
Mar 31, 2022 46.00
Dec 31, 2021 -271.00
Sep 30, 2021 2,608.00